Navigation Links
Synthetic Bone Tissue Could Be the Answer to Disfigurement Caused by Oral Cancer

Oral and pharyngeal cancers are by far the leading cancers in the world today. The problem is that these are not discovered until too late and thus the treatment, which includes radiation and surgery, involves // sacrificing a large amount of tissue leading to disfigurement.

Now two Virginia Tech researchers are collaborating with the American Dental Association (ADA) to build "a tissue engineered composite material for oral reconstruction." Brian Love, Virginia Tech professor of materials science and engineering, and principal investigator in this project stresses that they could provide "substantially better clinical outcomes for all oral constructions could result if a more viable scaffold material were used that was capable of faster and higher quality bone formation." His team is monitoring how amorphous calcium phosphates (ACPs) can play a role in the rebuilding of the lost tissue. "By constructing tissue engineered composites containing ACPs, living osteoblasts, and donor materials," Love said. The Paffenbarger Research Center of the ADA is providing the ACP required for this study. Aaron Goldstein of Virginia Tech's chemical engineering department, Drago Skrtic of the ADA Paffenbarger Research Center and Peter Shires of Virginia-Maryland Regional College of Veterinary Medicine are collaborating with Love in this particular venture. The details of this study are appearing in the forthcoming issues of the Journal of Biomaterials Science, Polymers Edition, and the Journal of Biomedical Materials Research. Contact: Lynn Nystrom tansy@vt.edu 540-231-4371 Virginia Tech
'"/>




Page: 1

Related medicine news :

1. New Study Will The Look Into The Effects Of Synthetic Steroids
2. Synthetic protein found to relieve arthritis symptoms in animal model
3. A Synthetic Molecule Instigates Cancer Cells To Self-Harm
4. Synthetic DNA Makes Better Hydrogels for Drug Delivery
5. Super Chow, Laced With Semi-Synthetic Vitamin E, Inhibited Spread of Cancer
6. Synthetic Chemicals May Trigger Breast Cancer
7. Synthetic Cannabinoid Could Improve Fertility in Smokers
8. Chemicals Used To Make Synthetic Color Can Cause Cancer And Permanent Blindness
9. Free Tissue Transfer Effective in Treating Massive Skin Cancers
10. Tissue Transfer for Skin Cancer
11. Tissue Transfer For Treatment Of Massive Skin Cancers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... ... 25, 2017 , ... Bellus Medical, a leader in medical ... new class of photodynamic cosmetics (PDC). , Allumera® is the first PDC cream ... of aging, and minimize the appearance of pores – all with minimal downtime ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... they have signed an agreement to be the preferred physical therapy provider for ... and returning them to Derby City CrossFit as quickly and effectively as possible, ...
(Date:4/25/2017)... ... April 25, 2017 , ... A stressful work environment ... can also decrease overall productivity and performance in the workplace. The goal of Clearview ... the last few weeks of April, Clearview Resolution Services will be shutting down the ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
(Date:4/19/2017)... THOUSAND OAKS, Calif. , April 19, 2017 ... premium industrial buildings it is developing at Conejo ... California , to Atara Biotherapeutics, Inc. ... patients with severe and life-threatening diseases that have ... focus on allogeneic T-cell therapies for cancer, autoimmune ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
Breaking Medicine Technology: